Close

Production & Manufacturing

CDMO to invest over €3m in GMP facility expansion

Spray drying specialist and capsule filling service provider Micro-Sphere is investing 3.5 million CHF (€3.2 million) into expanding its GMP manufacturing capabilities and processes. Micro-Sphere...

Sterling Pharma Solutions invests $1.5m into US facility expansion

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1.5m into a phased expansion of its US facility in North Carolina. The...

Covance Unveils New R&D Center in Shanghai

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that its Covance Drug Development business celebrated the...

Sharp’s Netherlands Facility Approved for Clinical Operations

Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and...

Sterling commences large-scale production of Nanologica’s silica particles

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has started large-scale production of Nanologica’s silica particles. Nanologica is a nanotechnology company specialising in...

Ardena Group launches Life Science Ingredients arm

Contract development and manufacturing organization (CDMO) Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients...

Catalent Biologics Announces Agreement To Provide Additional Production Of Approved Gene Therapy Treatment For Spinal Muscular Atrophy

Catalent Biologics announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for spinal muscular...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read